330 related articles for article (PubMed ID: 33327352)
1. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
An PP; Feng LN; Zhang XX; Jin QL
Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
[TBL] [Abstract][Full Text] [Related]
2. Association of Interleukin-6-174G/C Polymorphism With Ischemic Stroke: An Updated Meta-Analysis.
Chai J; Cao XL; Lu F
Front Neurol; 2021; 12():799022. PubMed ID: 35069427
[No Abstract] [Full Text] [Related]
3. Association between single nucleotide polymorphisms of IL-6 and susceptibility to skin cancer: a meta-analysis and systematic review.
Guo K; Lu Z; Wang X; Qiao J
Transl Cancer Res; 2021 Dec; 10(12):5110-5122. PubMed ID: 35116362
[TBL] [Abstract][Full Text] [Related]
4. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
[TBL] [Abstract][Full Text] [Related]
5. Association between
Rezaei F; Mohammadi H; Heydari M; Sadeghi M; Mozaffari HR; Khavid A; Godiny M; Brand S; M Dürsteler K; Beatrix Brühl A; Cordier D; Sadeghi-Bahmani D
Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33922260
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
7. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.
Wei YG; Liu F; Li B; Chen X; Ma Y; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
World J Gastroenterol; 2011 Sep; 17(34):3941-7. PubMed ID: 22025883
[TBL] [Abstract][Full Text] [Related]
9. Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.
Wu H; Wu X; Wan G; Zhang S
Int J Clin Exp Pathol; 2014; 7(10):6898-905. PubMed ID: 25400773
[TBL] [Abstract][Full Text] [Related]
10. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis.
Ma Y; Tang RK; Yang X; Peng GG; Liu Y; Wang XM; Wu BH; Yu JM
Hum Immunol; 2011 Aug; 72(8):641-51. PubMed ID: 21536090
[TBL] [Abstract][Full Text] [Related]
11. Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysis.
Liu Y; Gao SJ; Du BX; Wang JJ
Tumour Biol; 2014 Apr; 35(4):3551-61. PubMed ID: 24318992
[TBL] [Abstract][Full Text] [Related]
12. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
[No Abstract] [Full Text] [Related]
13. A meta-analysis on correlation between interleukin-6 -174G/C polymorphism and end-stage renal disease.
Feng Y; Tang Y; Zhou H; Xie K
Ren Fail; 2017 Nov; 39(1):350-356. PubMed ID: 28164733
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 gene -174G>C promoter polymorphism reduces the risk of periodontitis in Brazilian populations: A meta-analysis.
Mehar R; Swarnakar S; Lakkakula S; Verma HK; Bhaskar LVKS
J Oral Biosci; 2021 Dec; 63(4):388-393. PubMed ID: 34478874
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of IL-6 -174G/C polymorphism and psoriasis risk.
Nie G; Xie CL; Cao YJ; Xu MM; Shi X; Zou AL; Qi JH
Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421005
[TBL] [Abstract][Full Text] [Related]
17. Relationship between polymorphisms in -572G/C interleukin 6 promoter gene polymorphisms (rs1800796) and risk of rheumatoid arthritis: A meta-analysis.
Zhang C; Jiao S; Li T; Zhao L; Chen H
Int J Rheum Dis; 2020 Jan; 23(1):47-54. PubMed ID: 31782615
[TBL] [Abstract][Full Text] [Related]
18. The association between three IL-6 polymorphisms and HBV-related liver diseases: a meta-analysis.
Chang L; Lan T; Wu L; Li C; Yuan Y; Liu Z
Int J Clin Exp Med; 2015; 8(10):17036-45. PubMed ID: 26770294
[TBL] [Abstract][Full Text] [Related]
19. Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysis.
Kong C; Chen M; Fan X; Chen X
J Int Med Res; 2020 Aug; 48(8):300060520943420. PubMed ID: 32809897
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between IL-6 -174G>C polymorphism and lung cancer: a meta-analysis.
Liu Y; Song XL; Zhang GL; Peng AM; Fu PF; Li P; Tan M; Li X; Li M; Wang CH
Genet Mol Res; 2015 Jan; 14(1):163-9. PubMed ID: 25729947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
